Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Țară: Singapore

Limbă: engleză

Sursă: HSA (Health Sciences Authority)

Disponibil de la:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Clasă:

Class D medical device

Produs de:

Bio-Technology General (Israel) Ltd.

Zonă Terapeutică:

Orthopaedics

Indicații terapeutice:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Rezumat produs:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Data de autorizare:

2017-04-28